A new blood test may be key to diagnosing Alzheimer’s disease before the condition becomes debilitating.
Neuroscientists at New York University collected and analyzed the blood samples of 125 subjects for acetyl-L-carnitine (ALC) and free-carnitine, two markers essential for brain function.
These substances help to power cells, as well as regulate glutamate, which is involved in most brain activities.
Leave a reply